89BIO, INC. - Annual Financials - Cash Flow (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

89BIO, INC. - Annual Cash Flow (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Net loss	-367079	-142189	-102026
Stock-based compensation	20634	16106	10356
Accretion of discounts on marketable securities, net of amortization of premiums	9972	6242	980
Amortization of debt discount and accretion of deferred debt costs	831	874	764
Loss on extinguishment of debt	-1500	-1208
Noncash operating lease expense	721	223	175
Depreciation	38	50	65
Other	-29	-127
Prepaid and other assets	21726	6921	-3331
Accounts payable	7058	-3917	5659
Accrued expenses	-53	7876	1750
Operating lease liabilities	-496	-121	-184
Other non-current liabilities	689	3740
Net cash used in operating activities	-367823	-129186	-81090
Proceeds from sales and maturities of marketable securities	335225	218133	118760
Purchases of marketable securities	376074	341148	152696
Purchases of property and equipment	15	4	7
Net cash used in investing activities	-40864	-123019	-33943
Proceeds from issuance of common stock and warrants in public offerings, net of issuance costs	136283	458843	88239
Proceeds from issuance of common stock in at-the-market public offerings, net of issuance costs	21049	37089	28453
Proceeds from term loan facility, net of issuance costs	9349	24363
Proceeds from issuance of common stock upon exercise of common stock warrants	54207	15590	1082
Proceeds from issuance of common stock upon exercise of stock options	242	633	305
Proceeds from issuance of common stock under employee stock purchase plan	356	268	50
Payments of deferred offering costs	253	400
Payments for taxes related to net share settlement upon vesting of restricted stock units	2647	2275	298
Repayment of term loan		21400
Net cash provided by financing activities	218586	513111	117831
Net change in cash and cash equivalents, and restricted cash	-190101	260906	2798
Cash and cash equivalents at beginning of period	126060	316161	55255
Cash and cash equivalents at end of period	126060	316161	55255
Cash paid for interest	3135	2593	1076
Cash paid for amounts included in the measurement of lease liabilities	774	185	234
Unpaid offering costs included in accrued expenses		253
Right-of-use assets obtained in exchange for new operating lease liabilities		2080
Remeasurement of lease liability and right of use asset in connection with lease modification			338
Issuance of common stock warrants in connection with term loans	608	482